the highest risk of mortality. 1 – 8 Although both cancer and CVD have been independently associated with higher COVID-19–associated adverse outcomes, outcomes for patients with COVID-19 afflicted with a dual diagnosis of cancer and
Search Results
Sarju Ganatra, Sourbha S. Dani, Robert Redd, Kimberly Rieger-Christ, Rushin Patel, Rohan Parikh, Aarti Asnani, Vigyan Bang, Katherine Shreyder, Simarjeet S. Brar, Amitoj Singh, Dhruv S. Kazi, Avirup Guha, Salim S. Hayek, Ana Barac, Krishna S. Gunturu, Corrine Zarwan, Anne C. Mosenthal, Shakeeb A. Yunus, Amudha Kumar, Jaymin M. Patel, Richard D. Patten, David M. Venesy, Sachin P. Shah, Frederic S. Resnic, Anju Nohria, and Suzanne J. Baron
Laura Spring, Rachel Greenup, Andrzej Niemierko, Lidia Schapira, Stephanie Haddad, Rachel Jimenez, Suzanne Coopey, Alphonse Taghian, Kevin S. Hughes, Steven J. Isakoff, Leif W. Ellisen, Barbara L. Smith, Michelle Specht, Beverly Moy, and Aditya Bardia
, offers an efficient mechanism to explore predictive biomarkers and triage novel agents. 11 – 14 However, the prognostic significance of pCR after NAC has been somewhat controversial, and its surrogacy for long-term outcomes is much less studied in
Sarah T. Le, Pritesh S. Karia, Beverley J. Vollenhoven, Robert J. Besaw, Colleen M. Feltmate, and Chrysalyne D. Schmults
-adjusted incidence of vSCC is 2.5 per 100,000 women. 3 The most significant prognostic factor for vSCC is lymph node status. 4 , 5 Other factors associated with poor outcomes include age, tumor diameter, tumor depth, tumor class, histologic grade, lymphovascular
Ashish Rai, Xuesong Han, Zhiyuan Zheng, K. Robin Yabroff, and Ahmedin Jemal
) mandated the adjustment of Medicare payment rates in response to value-based performance scores—a substantive portion of which is measured using patients' assessment of communication with healthcare providers. 2 The Patient-Centered Outcomes Research
Grace L. Smith, Maria A. Lopez-Olivo, Pragati G. Advani, Matthew S. Ning, Yimin Geng, Sharon H. Giordano, and Robert J. Volk
and intervention in vulnerable patients, 18 a comprehensive synthesis of the risk factors for and outcomes of financial burdens is needed. We therefore conducted a systematic review of these risk factors and outcomes across studies of US patients with
Linda Watson, Siwei Qi, Andrea DeIure, Eclair Photitai, Lindsi Chmielewski, and Louise Smith
lower functioning and quality of life. 2 , 5 , 6 Therefore, it is critical to identify patients experiencing severe symptom complexity so that timely, targeted symptom management can be delivered. With research showing benefits of gathering outcome data
Brad Zebrack and Melissa Butler
recent study of AYA patients with cancer found that engaging with music (listening, performing, rehearsing, practicing, composing, dancing, and imagery) resulted in adaptive outcomes, including the promotion of identity formation and a perceived sense of
Jesse D. Troy, Carlos M. de Castro, Mary Ruth Pupa, Greg P. Samsa, Amy P. Abernethy, and Thomas W. LeBlanc
distress has been associated with reduced survival in some cancers. 4 – 6 Myelodysplastic syndromes (MDS) are diagnosed primarily in older people and represent a diverse group of malignant bone marrow disorders with variable clinical outcome. 7 QOL is
Walburga Yvonne Joko-Fru, Mirko Griesel, Nikolaus Christian Simon Mezger, Lucia Hämmerl, Tobias Paul Seraphin, Jana Feuchtner, Henry Wabinga, Guy N’da, Assefa Mathewos, Bakarou Kamaté, Judith Nsonde Malanda, Freddy Houéhanou Rodrigue Gnangnon, Gladys Chebet Chesumbai, Anne Korir, Cesaltina Lorenzoni, Annelle Zietsman, Margaret Ziona Borok, Biying Liu, Christoph Thomssen, Paul McGale, Ahmedin Jemal, Donald Maxwell Parkin, and Eva Johanna Kantelhardt
using SPSS Statistics, version 25 (IBM Corp) and data analyses were performed with STATA, version 14.2 (StataCorp, LP). Explanatory and Outcome Measures The main explanatory variable was the therapy received. The outcome measure was the patients
Walburga Yvonne Joko-Fru, Mirko Griesel, Nikolaus Christian Simon Mezger, Lucia Hämmerl, Tobias Paul Seraphin, Jana Feuchtner, Henry Wabinga, Guy N’da, Assefa Mathewos, Bakarou Kamaté, Judith Nsonde Malanda, Freddy Houéhanou Rodrigue Gnangnon, Gladys Chebet Chesumbai, Anne Korir, Cesaltina Lorenzoni, Annelle Zietsman, Margaret Ziona Borok, Biying Liu, Christoph Thomssen, Paul McGale, Ahmedin Jemal, Donald Maxwell Parkin, and Eva Johanna Kantelhardt
using SPSS Statistics, version 25 (IBM Corp) and data analyses were performed with STATA, version 14.2 (StataCorp, LP). Explanatory and Outcome Measures The main explanatory variable was the therapy received. The outcome measure was the patients
